American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$223M |
| 2 |
Fortive
FTV
|
+$192M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$175M |
| 4 |
American Water Works
AWK
|
+$137M |
| 5 |
Medtronic
MDT
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MXIM
Maxim Integrated Products
MXIM
|
+$400M |
| 2 |
Becton Dickinson
BDX
|
+$295M |
| 3 |
Cummins
CMI
|
+$259M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$253M |
| 5 |
Kimberly-Clark
KMB
|
+$252M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.68% |
| 2 | Healthcare | 15.63% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Financials | 13.63% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSH
76
Marsh
MRSH
$90.1B
| $348M | 0.31% |
3,036,192
-93,653
| -3% | -$10.7M |
|
77
Merck
MRK
$328B
| $347M | 0.31% |
4,381,165
-855,617
| -16% | -$67M |
|
78
Illumina
ILMN
$29.1B
| $345M | 0.31% |
1,146,940
-34,752
| -3% | -$12M |
|
79
Cognex
CGNX
$10.2B
| $344M | 0.31% |
5,287,015
+289,412
| +6% | +$18.7M |
|
80
Republic Services
RSG
$65.6B
| $342M | 0.3% |
3,668,666
-127,757
| -3% | -$11.4M |
|
81
Johnson Controls International
JCI
$92.6B
| $337M | 0.3% |
8,250,017
-1,226,033
| -13% | -$48M |
|
82
L3Harris
LHX
$54.1B
| $337M | 0.3% |
1,981,841
-120,465
| -6% | -$21.1M |
|
83
FMC
FMC
$1.28B
| $336M | 0.3% |
3,177,209
-108,892
| -3% | -$11.7M |
|
84
Booking.com
BKNG
$159B
| $333M | 0.3% |
4,863,225
+852,950
| +21% | +$59.9M |
|
85
Advanced Micro Devices
AMD
$788B
| $331M | 0.29% |
4,034,557
+91,577
| +2% | +$6.8M |
|
|
XLNX
86
DELISTED
Xilinx Inc
XLNX
| $328M | 0.29% |
3,142,597
+579,097
| +23% | +$59.5M |
|
|
SPLK
87
DELISTED
Splunk Inc
SPLK
| $322M | 0.29% |
1,709,882
+181,873
| +12% | +$36.2M |
|
88
Constellation Brands
STZ
$22.9B
| $321M | 0.28% |
1,694,251
-80,170
| -5% | -$14.6M |
|
89
CoStar Group
CSGP
$12.4B
| $320M | 0.28% |
3,775,100
+616,190
| +20% | +$49.1M |
|
90
Bristol-Myers Squibb
BMY
$130B
| $314M | 0.28% |
5,207,739
-265,394
| -5% | -$16M |
|
91
F5
FFIV
$24B
| $310M | 0.28% |
2,527,667
+334,462
| +15% | +$45M |
|
|
CTLT
92
DELISTED
CATALENT, INC.
CTLT
| $309M | 0.27% |
3,602,800
-146,802
| -4% | -$12.4M |
|
93
Berkshire Hathaway Class B
BRK.B
$1.09T
| $306M | 0.27% |
1,436,217
+45,065
| +3% | +$9.22M |
|
94
Amgen
AMGN
$225B
| $305M | 0.27% |
1,201,528
-44,655
| -4% | -$11.1M |
|
95
Biogen
BIIB
$30.9B
| $303M | 0.27% |
1,068,008
+35,366
| +3% | +$9.86M |
|
96
S&P Global
SPGI
$121B
| $302M | 0.27% |
837,499
+184,381
| +28% | +$65.1M |
|
97
Bio-Rad Laboratories Class A
BIO
$9.68B
| $302M | 0.27% |
585,817
-78,043
| -12% | -$39.5M |
|
98
GDS Holdings
GDS
$6.56B
| $294M | 0.26% |
3,595,682
-1,232,416
| -26% | -$98.7M |
|
99
Broadcom
AVGO
$1.98T
| $291M | 0.26% |
7,986,030
-764,690
| -9% | -$25.6M |
|
|
100
Becton Dickinson
BDX
$50B
| $291M | 0.26% |
1,279,824
-1,200,851
| -48% | -$295M |
|
Similar funds
American Century Companies's Q3 2020 Portfolio in Review
As of Q3 2020, American Century Companies held 1,900 positions worth $113B, up 6.9% from $105B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
American Century Companies's Q3 2020 filing shows 187 new, 982 increased, 613 reduced and 100 closed positions. Its largest new stake was Fortive: 4,206,223 shares worth $202M. The largest sale was Maxim Integrated Products, an estimated $400M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- American Century Companies's largest Q3 2020 buy was Fortive: 4,206,223 shares worth $202M.
- American Century Companies added most to PepsiCo in Q3 2020, an estimated $223M increase.
- American Century Companies's biggest Q3 2020 reduction was Maxim Integrated Products, cutting an estimated $400M.
- American Century Companies fully exited Service Corp International in Q3 2020, selling an estimated $89.5M.
- American Century Companies's ten largest holdings make up 23% of its $113B portfolio in Q3 2020.
- American Century Companies opened 187 new positions and closed 100 in Q3 2020.
- American Century Companies's portfolio value rose 6.9% quarter-over-quarter to $113B.
Based on American Century Companies's 13F filing for Q3 2020, filed 13 Nov 2020.